These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37982356)

  • 1. Exploring the burden of mixed dyslipidemia in patients with type 2 diabetes mellitus: A cross-sectional study in Kashmir, India.
    Lone SS; Majid S; Bhat MH; Wani GA
    Am J Hum Biol; 2024 Apr; 36(4):e24012. PubMed ID: 37982356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes.
    Zhou K; Qin Z; Tian J; Cui K; Yan Y; Lyu S
    Angiology; 2021 Nov; 72(10):934-941. PubMed ID: 33949211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross-sectional survey of a regional cohort.
    Yadegar A; Mohammadi F; Rabizadeh S; Ayati A; Seyedi SA; Nabipoorashrafi SA; Esteghamati A; Nakhjavani M
    J Clin Lab Anal; 2023 Jul; 37(13-14):e24954. PubMed ID: 37537785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Dyslipidaemia Using an Algorithm of Lipid Profile Measures among Newly Diagnosed Type II Diabetes Mellitus Patients: A Cross-Sectional Study at Dormaa Presbyterian Hospital, Ghana.
    Anto EO; Obirikorang C; Annani-Akollor ME; Adua E; Donkor S; Acheampong E; Asamoah EA
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31330902
    [No Abstract]   [Full Text] [Related]  

  • 5. The pattern of dyslipidemia among Somali type 2 diabetic patients: a cross-sectional study.
    Alıcı G; Genç Ö
    Eur J Med Res; 2022 Nov; 27(1):253. PubMed ID: 36404351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albuminuria status and patterns of dyslipidemia among type 2 diabetes black patients managed at a tertiary health-care hospital: A
    Kajingulu FM; Lepira FB; Mbutiwi FI; Makulo JR; Sumaili EK; Bukabau JB; Mokoli VM; Longo AL; Nseka NM
    Saudi J Kidney Dis Transpl; 2018; 29(3):649-657. PubMed ID: 29970743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing trend of blood lipid profile in type 2 diabetes: Not a promising change in HDL-C, a serial cross-sectional study.
    Yadegar A; Mohammadi F; Rabizadeh S; Meysamie A; Nabipoorashrafi SA; Seyedi SA; Esteghamati A; Nakhjavani M
    PLoS One; 2023; 18(10):e0293410. PubMed ID: 37878656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
    Selim S; Alam MS; Talukder SK; Kabir ML; Gaffar AJ; Kabir MA; Zarin N; Rahman S; Nabi MMU; Mustari M; Hossain MF; Raunak AIB; Hoque MA; Islam MR; Akter F; Hannan MA; Saifuddin M; Asaduzzaman M; Rahman MM; Ahammed A; Rafi MA; Hasan MJ; Kamrul-Hasan ABM
    BMC Endocr Disord; 2023 Dec; 23(1):268. PubMed ID: 38053073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria.
    Bello-Ovosi BO; Ovosi JO; Ogunsina MA; Asuke S; Ibrahim MS
    Pan Afr Med J; 2019; 34():123. PubMed ID: 33708292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.
    Colhoun HM; Leiter LA; Müller-Wieland D; Cariou B; Ray KK; Tinahones FJ; Domenger C; Letierce A; Israel M; Samuel R; Del Prato S
    Cardiovasc Diabetol; 2020 Feb; 19(1):14. PubMed ID: 32035487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
    Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
    Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
    He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
    Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes.
    Pokharel DR; Khadka D; Sigdel M; Yadav NK; Acharya S; Kafle R; Sapkota RM; Sigdel T
    BMC Res Notes; 2017 Apr; 10(1):146. PubMed ID: 28376848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility of the Logarithmically Transformed Ratio of Triglycerides-to- High-Density Lipoprotein Cholesterol and Its Relationship with Other Atherosclerosis-Related Lipid Factors in Type 2 Diabetes.
    Viktorinova A; Fabryova L; Malickova D; Choudhury S; Krizko M
    Metab Syndr Relat Disord; 2021 May; 19(4):205-212. PubMed ID: 33373539
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.
    Hermans MP; Ahn SA; Rousseau MF
    Cardiovasc Diabetol; 2010 Dec; 9():88. PubMed ID: 21156040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women.
    Wu TT; Gao Y; Zheng YY; Ma YT; Xie X
    Lipids Health Dis; 2018 Aug; 17(1):197. PubMed ID: 30134981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus.
    Cui R; Qi Z; Zhou L; Li Z; Li Q; Zhang J
    Clin Interv Aging; 2016; 11():445-52. PubMed ID: 27143868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.